In the treated group, the LIVP-RFP cytokine analysis suggested elevation of CXCL10 in the tumor samples and IFN-α, IFN-γ, CCL2, CCL3, CXCL9, and CXCL10 in the sera samples. The gene discussed is IFNA1; the disease is neoplasm.